 send to a friend by email
2008-02-12
Palestine securities exchange received the preliminary revised financial statements from the internal auditors of Jerusalem Pharmaceutical Company, as of December 31, 2007. This disclosure came within the applied disclosures system, which grants every listed company a month and a half as utmost period for disclosing the preliminary financial results of 2007. It is revealed by the in formations presented by the JPH that, it had been disclosed using the electronic reporting standard, and a signed paper copy of the internal audited preliminary financials was sent to be verified from the board of directors parallel with another copy that had been sent to the CMA and PSE. Also the annual report of the JPH will be published in March, 2008. As for the general assembly meeting it will be held in April, 2008 to discuss these financial results. This preliminary financials were published on the PSE website as soon as it released by the JPH. JPH"s financial results pointed out to gross income of 1,724,460 JD to the year 2007 versus 1,867,147 JD in 2006. Total assets amounted 22,185,305 JD in 2007 after amounting 20,335,648 JD in the year 2006. It is also noticed that the total liabilities had soared to amount 2,713,012 JD versus 2,652,424 JD in the same period of 2006. Shareholders" equity increased in 2007 to 19,472,293 JD after it had amounted 17,683,224 JD in 2006.
|
|
-trade
